AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 91 min read$RYAN

MULSHINE BRENDAN MARTIN sold $1.6M of RYAN

MULSHINE BRENDAN MARTIN (Co-President and CRO) sold 40,000 shares of RYAN SPECIALTY HOLDINGS, INC. (RYAN) at $40.51 ($1.62M total) on 2026-09-08.

Original reporting
SEC EDGAR · MULSHINE BRENDAN MARTIN
Published Sep 9, 2026, 9:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 9:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$RYAN
Bearish
medium confidence
Mentioned
$RYAN
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RYANBearishLow
01

Why it matters

The disclosed sale may lead to short-term price weakness, but the overall impact is limited given the modest size relative to market cap.

02

Market read

Primary insider sale provides new information for traders monitoring RYAN.

03

What to watch

No indication of upcoming earnings or corporate events that might explain the sale.

Relevance 6/10Novelty 6/10Timing: post-market 2026-09-08

Background

Form 4 filings disclose insider transactions and are used by traders to gauge insider sentiment.

Company-level read

Ticker impact

$RYANBearishMedium confidence
Context

Co-President Brendan Martin sold 40,000 shares for $1.62M on 2026-09-08, reducing his stake to 75,366 shares.

Expected impact

Possible modest downside pressure in the next trading session.

Evidence & confidence

Sale size is moderate ($1.6M) and the insider holds a senior role, which can influence market perception.

Market effects

Sector

Minimal; the sale does not affect the broader specialty chemicals sector.

Regional

Limited to U.S. investors tracking insider activity.

Global

Low

Counterpoint

What could challenge this read

The sale could be a routine portfolio rebalancing rather than a negative signal.

Key entities

  • Insider
    Brendan Martin

    Co-President and Chief Risk Officer of Ryan Specialty Holdings.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

RYAN insider trading history →

Related articles

JUL 31
$RYANMedAI 8/10

Ryan Specialty posts Q2 revenue gain as E&S market slows

Ryan Specialty Holdings, Inc. reported second-quarter 2026 net commissions and fees of $902.7 million, up 7.4% year-over-year. Total revenue for the quarter reached $916.6 million, a 7.2% increase from $855.2 million a year earlier. Organic revenue growth came in at 6.7%, down from 7.1% in the prior-year period. The deceleration continues a trend across multiple quarters as the broader E&S market moderates.

insurancebusinessmag.com6 min
JUL 30
$RYANMed

RYAN SPECIALTY REPORTS SECOND QUARTER 2026 RESULTS

RYAN SPECIALTY HOLDINGS, INC. (RYAN) filed an SEC Form 8-K — Results of Operations and Financial Condition. 1 RYAN SPECIALTY REPORTS SECOND QUARTER 2026 RESULTS - Total Revenue grew 7.2% year-over-year to $916.6 million - - Organic Revenue Growth Rate* of 6.7% year-over-year - - Net Income of $108.4 million , or $0.33 per diluted share - - Adjusted EBITDAC* grew 6.0% year-over-year to

SEC EDGAR 8-K6 min